Related Experiment Video
Updated: May 16, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Clinical outcome after mitral valve surgery due to ischemic papillary muscle rupture
Thomas Schroeter1, Sven Lehmann, Martin Misfeld
1Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig, Leipzig, Germany. thomas-schroeter@gmx.de
Background:
Severe mitral regurgitation secondary to papillary muscle rupture is an infrequent but catastrophic complication after myocardial infarction. Without surgical treatment, mortality can reach 80%, but surgical treatment also carries substantial perioperative morbidity and mortality.
Methods:
We retrospectively analyzed 28 patients who underwent mitral valve surgery for ischemic papillary muscle rupture.
Results:
The 30-day mortality rate was 39.3% (11 of 28). There were no significant differences in the baseline characteristics, and concomitant coronary artery bypass (CABG) was performed in 66.7% of the survivor group and in 61.5% of the nonsurvivor group (p = 0.245). Mortality predictors included low cardiac output (p = 0.05), renal failure (p = 0.005), and implementation of extracorporeal membrane oxygenation therapy (p = 0.005). The time between myocardial infarction and surgery showed no significant effects on survival.
Conclusions:
Papillary muscle rupture with severe mitral regurgitation carries a high operative mortality. Additional CABG does not influence the acute postoperative course. Postoperative development of low cardiac output with a need for extracorporeal membrane oxygenation therapy and renal failure with hemodialysis substantially reduces survival.
Insights
Severe mitral regurgitation from papillary muscle rupture after heart attack has high mortality. Post-surgery complications like low cardiac output and renal failure significantly reduce survival rates.
Area of Science:
- Cardiology
- Cardiac Surgery
- Critical Care Medicine
Background:
- Papillary muscle rupture causing severe mitral regurgitation is a rare but devastating myocardial infarction complication.
- Untreated mortality approaches 80%, while surgical intervention carries significant risks.
Purpose of the Study:
- To evaluate the outcomes of mitral valve surgery in patients with ischemic papillary muscle rupture.
- To identify predictors of mortality in this high-risk patient group.
Main Methods:
- Retrospective analysis of 28 patients undergoing mitral valve surgery for ischemic papillary muscle rupture.
- Assessment of baseline characteristics, concomitant procedures, and postoperative outcomes.
Main Results:
- 30-day mortality was 39.3% (11 of 28 patients).
- Mortality predictors included low cardiac output, renal failure, and extracorporeal membrane oxygenation (ECMO) therapy.
- Concomitant coronary artery bypass grafting (CABG) did not significantly impact survival.
Conclusions:
- Papillary muscle rupture with severe mitral regurgitation has high operative mortality.
- Postoperative low cardiac output, need for ECMO, and renal failure requiring hemodialysis are associated with reduced survival.
- Additional CABG does not improve acute postoperative outcomes.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction

